Peetz Christopher
SEC insider (Form 3/4/5 filer). CIK 0001614740. CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM) and 1 other issuer. 52 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in FOSTER CITY, CA.
Companies Peetz Christopher has filed insider reports for
- Mirum Pharmaceuticals, Inc. (MIRM): Director, Officer, CHIEF EXECUTIVE OFFICER
- Arcutis Biotherapeutics, Inc. (ARQT): Director
Peetz Christopher
CIK: 0001614740
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (52 total)
- Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect5.3K shares at avg. $19.19$102K - Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect6.9K shares at avg. $15.87$109K - Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect8.3K shares at avg. $98.08$815K - Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect30K shares at avg. $2.94$88K - Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect21.7K shares at avg. $98.91$2.1M - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect20K shares at avg. $2.94$59K - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect2.3K shares at avg. $100.14$230K - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect11.7K shares at avg. $98.51$1.2M - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
SaleDirect6K shares at avg. $99.25$597K - Jul 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
AwardDirect4.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  MIRM Mirum Pharmaceuticals, Inc. | Exercise | 5,305 | $19.19 | $101,803 | Direct |
| Oct 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 6,892 | $15.87 | $109,376 | Direct |
| Sep 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 8,312 | $98.08 | $815,241 | Direct |
| Sep 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 30,000 | $2.94 | $88,080 | Direct |
| Sep 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 21,688 | $98.91 | $2,145,160 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 20,000 | $2.94 | $58,720 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 2,300 | $100.14 | $230,322 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 11,683 | $98.51 | $1,150,892 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale | 6,017 | $99.25 | $597,187 | Direct |
| Jul 15, 2026 |  ARQT Arcutis Biotherapeutics, Inc. | Award | 4,315 | - | $0 | Direct |
1-10 of 52 transactions